Queensland is home to a cluster of agile, innovative and entrepreneurial biomedical businesses.
Our pre-clinical and early-phase clinical trial capabilities are underpinned by sophisticated academic health translation research infrastructure.
We are on track to become a globally competitive Asia-Pacific biomedical industry hub by 2027.
The Queensland Biomedical 10-Year Roadmap and Action Plan ( 605.5 KB) sets out how we are going to grow, support and attract biomedical enterprises over the next five years and beyond.
- Supported research infrastructure like the Australian National Fabrication Facility Queensland and Griffith Institute for Drug Discovery Compounds Australia facility through the Research Infrastructure Co-investment fund
- 4 biomedical businesses were supported under the Queensland Biomedical Voucher Program
- Promoted Queensland’s biomedical capabilities at events like:
- JP Morgan Week (USA)
- BIO Korea
- BIO Japan
- BIO USA
- Co-hosted a showcase event to highlight Queensland’s expertise in Precision Medicine and Clinical Trials
- Fostered a partnership between Sanofi, the University of Queensland and Griffith University to create the $280 million Translational Science Hub in Brisbane
- Released a refreshed version of the Queensland Biomedical 10-Year Roadmap and Action Plan, highlighting Queensland's successes in enhancing existing industry strengths and opportunities while positioning our state as the leader for this world-changing industry in the Asia-Pacific region.
Queensland's biomedical sector
Queensland is in an ideal position to continue to attract international companies and to build sovereign capability in areas such as the development, manufacture and the delivery of vaccines.
A$2.11 billion estimated annual gross value added to the Queensland economy
12,400 people employed
Export value estimated at $477.6 million
- global expertise in tropical medicine and infectious diseases
- world-class research base within key innovation precincts
- high-value niche businesses supported by an established network of service providers
- expertise in e-health, comprehensive pathology information and telemedicine
- home to two of Australia's leading biopharmaceutical contract manufacturers.
Why invest in Queensland’s biomedical sector
- World-class biomedical ecosystem
- Over two decades of state government investment in science and innovation
- Fast, pragmatic regulatory pathway with rapid ethics approval
- Clinical data complies with top international standards
- Superior scientific talent and excellent research and medical infrastructure.
- World-class training, teaching and research facilities
- Highly skilled workforce with strong technical and academic collaboration
- Brain gain: many Queenslanders have returned home with experience in international markets.
- Enviable, relaxed lifestyle and world-famous natural attractions
- Lowest median house price in a capital city on the east coast
- Average of 300 days of sunshine annually.
- Over 5 million residents with strong population growth and immigration from other states.
- Very competitive business costs
- Low payroll tax, high exemption threshold (A$1.3 million)
- Stable economic and political environment and the most decentralised of mainland Australian states
- Over 27 years of economic growth in Queensland and Australia.
- Strategic location with access to and shared time zones with high growth markets in the Asia-Pacific region
- Five international passenger airports with direct connectivity to global markets.
Industry support and attraction incentives
We’re helping Queensland biomedical small-to-medium businesses like yours find funding and support to help you grow. Assistance programs are often designed to be accessed throughout different stages of the business lifecycle, so you can find the right opportunity for your business.
AusBiotech is the premier annual conference for Australia’s life sciences sector, bringing together over 1,000 Australian and international biotech delegates, sponsors, speakers and exhibitors both face-to-face and virtually to Brisbane for a three-day comprehensive program of partnering activities, education, skills building, exhibition and networking for partnering and investment. AusBiotech 2023 will include:
- Pre-conference workshops and facility tours.
- Conference, exhibition opening, plenary keynotes and concurrently run sessions, welcome function.
- Conference, exhibition, plenary keynotes, concurrently run sessions, and conference dinner.
- The Early Stage Investment Event is a one-day investment event running concurrently with the AusBiotech 2023. This event will connect leading biotech innovators and the early-stage investment community to fund the future of life sciences.
- Conference, exhibition, plenary keynotes, early-stage investment stream, closing ceremony.
The conference will create a forum to reflect on the sector’s achievements and exchange ideas on a range of topics to further advance the sector’s standing both nationally and globally. AusBiotech offers the opportunity to:
- Connect with speakers travelling from around the globe and more than 100 exhibiting companies representing the life sciences.
- Gain insight from and network with experts, researchers, industry leaders and leading companies within life sciences.
- Attend tailored events, sessions and registration options to align with delegates’ professional, research, career and business goals.
- Access the latest research, trends and insights from within the global life sciences ecosystem
- Professionally network with AusPartnering, AusBiotech’s highly recommended business matching program, to arrange private meetings between conference delegates.
Last updated: 02 Feb 2023